RDHL
RedHill Biopharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.72
+1.63%0
Insider buys (3m)
1
Insider sells (3m)
-$1.4K
Net value (3m)
-28.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 13, 2026 | Raday Gilead · officer: Chief Operating Officer | Sale | 14,130,000 | $0.00 |
| Jul 13, 2026 | Raday Gilead · officer: Chief Operating Officer | M-Exempt | 28,150,000 | $0.00 |
| Apr 22, 2026 | Raday Gilead · officer: Chief Operating Officer | Sale | 15,740,000 | $0.00 |
| Apr 22, 2026 | Raday Gilead · officer: Chief Operating Officer | M-Exempt | 30,780,000 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 13, 2026